Immunomedics, still searching for first approval, discloses forthcoming FDA re-inspection

The Food and Drug Administration will conduct a re-inspection of Immunomedics' manufacturing facility in Morris Plains, New Jersey, as part of the process for the company to re-submit its new drug application, according to a Thursday filing with the Securities and Exchange Commission.